{"id":"https://openalex.org/W2000110844","doi":"https://doi.org/10.1111/j.1432-1033.1984.tb08355.x","title":"Activation of the ppp(A2'p)nA system in interferon-treated, Herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase","display_name":"Activation of the ppp(A2'p)nA system in interferon-treated, Herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase","alternate_titles":[],"publication_year":1984,"publication_date":"1984-08-01","ids":{"openalex":"https://openalex.org/W2000110844","doi":"https://doi.org/10.1111/j.1432-1033.1984.tb08355.x","mag":"2000110844","pmid":"https://pubmed.ncbi.nlm.nih.gov/6088228"},"language":"en","primary_location":{"id":"doi:10.1111/j.1432-1033.1984.tb08355.x","doi":"https://doi.org/10.1111/j.1432-1033.1984.tb08355.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1432-1033.1984.tb08355.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1432-1033.1984.tb08355.x","source":{"id":"https://openalex.org/S4210214924","display_name":"European Journal of Biochemistry","issn_l":"0014-2956","issn":["0014-2956","0945-5795","1432-1033"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Biochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000110844"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1432-1033.1984.tb08355.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059520420","display_name":"P. Jane CAYLEY","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Jane CAYLEY","raw_affiliation_strings":["Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London, England WC2A 3PX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London, England WC2A 3PX","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"John A. DAVIES","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John A. DAVIES","raw_affiliation_strings":["Searle Research and Development Division, G. D. Searle & Co. Ltd.Lane End Road, High Wycombe, Buckinghamshire, England HP12 4HL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Searle Research and Development Division, G. D. Searle & Co. Ltd.Lane End Road, High Wycombe, Buckinghamshire, England HP12 4HL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049952115","display_name":"Keith G. McCullagh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keith G. McCULLAGH","raw_affiliation_strings":["Searle Research and Development Division, G. D. Searle & Co. Ltd.Lane End Road, High Wycombe, Buckinghamshire, England HP12 4HL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Searle Research and Development Division, G. D. Searle & Co. Ltd.Lane End Road, High Wycombe, Buckinghamshire, England HP12 4HL","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029776635","display_name":"Ian Macpherson Kerr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ian M. KERR","raw_affiliation_strings":["Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London, England WC2A 3PX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London, England WC2A 3PX","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2256,"has_fulltext":true,"cited_by_count":135,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.88555996,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"143","issue":"1","first_page":"165","last_page":"174"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11135","display_name":"Virology and Viral Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/2-5-oligoadenylate","display_name":"2',5'-oligoadenylate","score":0.8009999990463257},{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.7200000286102295},{"id":"https://openalex.org/keywords/herpes-simplex-virus","display_name":"herpes simplex virus","score":0.7950000166893005},{"id":"https://openalex.org/keywords/herpes-simplex-virus-type-1","display_name":"herpes simplex virus type 1","score":0.6899999976158142},{"id":"https://openalex.org/keywords/herpes-simplex-virus-type-2","display_name":"herpes simplex virus type 2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/encephalomyocarditis-virus","display_name":"encephalomyocarditis virus","score":0.9919999837875366},{"id":"https://openalex.org/keywords/rrna-cleavage","display_name":"rRNA cleavage","score":0.8199999928474426},{"id":"https://openalex.org/keywords/protein-synthesis-inhibition","display_name":"protein synthesis inhibition","score":0.5640000104904175},{"id":"https://openalex.org/keywords/rnase-inhibitor","display_name":"RNase inhibitor","score":0.5690000057220459},{"id":"https://openalex.org/keywords/chang-cells","display_name":"Chang cells","score":0.7289999723434448}],"concepts":[{"id":"https://openalex.org/C2781196997","wikidata":"https://www.wikidata.org/wiki/Q655331","display_name":"Herpes simplex virus","level":3,"score":0.7491687536239624},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5598494410514832},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.5567036867141724},{"id":"https://openalex.org/C10879258","wikidata":"https://www.wikidata.org/wiki/Q76826611","display_name":"RNase P","level":4,"score":0.5425889492034912},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47693318128585815},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3291912078857422},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29241234064102173},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.1656198799610138},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11669927835464478},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08132529258728027}],"mesh":[{"descriptor_ui":"D000227","descriptor_name":"Adenine Nucleotides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002472","descriptor_name":"Cell Transformation, Viral","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004587","descriptor_name":"Electrophoresis, Agar Gel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004722","descriptor_name":"Endoribonucleases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009843","descriptor_name":"Oligoribonucleotides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012260","descriptor_name":"Ribonucleases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D012335","descriptor_name":"RNA, Ribosomal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014176","descriptor_name":"Protein Biosynthesis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018139","descriptor_name":"Simplexvirus","qualifier_ui":"Q000254","qualifier_name":"growth & development","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1432-1033.1984.tb08355.x","doi":"https://doi.org/10.1111/j.1432-1033.1984.tb08355.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1432-1033.1984.tb08355.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1432-1033.1984.tb08355.x","source":{"id":"https://openalex.org/S4210214924","display_name":"European Journal of Biochemistry","issn_l":"0014-2956","issn":["0014-2956","0945-5795","1432-1033"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Biochemistry","raw_type":"journal-article"},{"id":"pmid:6088228","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6088228","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of biochemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1432-1033.1984.tb08355.x","doi":"https://doi.org/10.1111/j.1432-1033.1984.tb08355.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1432-1033.1984.tb08355.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1432-1033.1984.tb08355.x","source":{"id":"https://openalex.org/S4210214924","display_name":"European Journal of Biochemistry","issn_l":"0014-2956","issn":["0014-2956","0945-5795","1432-1033"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-100"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Biochemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000110844.pdf","grobid_xml":"https://content.openalex.org/works/W2000110844.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W991598983","https://openalex.org/W1498679844","https://openalex.org/W1523552677","https://openalex.org/W1526304027","https://openalex.org/W1558747066","https://openalex.org/W1561048695","https://openalex.org/W1861383991","https://openalex.org/W1949762533","https://openalex.org/W1974429192","https://openalex.org/W1975381946","https://openalex.org/W1981725382","https://openalex.org/W1985660340","https://openalex.org/W1999087217","https://openalex.org/W1999259276","https://openalex.org/W1999867700","https://openalex.org/W2008391176","https://openalex.org/W2009304163","https://openalex.org/W2026729363","https://openalex.org/W2030131332","https://openalex.org/W2035488179","https://openalex.org/W2037957091","https://openalex.org/W2039361749","https://openalex.org/W2041169105","https://openalex.org/W2045344712","https://openalex.org/W2060834058","https://openalex.org/W2061313150","https://openalex.org/W2066342343","https://openalex.org/W2067171614","https://openalex.org/W2069514830","https://openalex.org/W2085552343","https://openalex.org/W2088924903","https://openalex.org/W2098504102","https://openalex.org/W2112834292","https://openalex.org/W2122994357","https://openalex.org/W2132641862","https://openalex.org/W2140974054"],"related_works":["https://openalex.org/W1526304027","https://openalex.org/W2083289145","https://openalex.org/W2082786982","https://openalex.org/W1537683572","https://openalex.org/W166257218","https://openalex.org/W2062097395","https://openalex.org/W2314702460","https://openalex.org/W1533057620","https://openalex.org/W1505592466","https://openalex.org/W1983826040"],"abstract_inverted_index":{"High":[0],"doses":[1,35,56],"(100-1000":[2],"reference":[3,37],"units/ml)":[4,38],"of":[5,16,39,43,64,78,81,99,103,115,145,177,188,213,227,249,259,263,271,285,287],"alpha":[6,121],"or":[7,122,137,200],"beta":[8,123],"interferons":[9,69],"are":[10],"required":[11],"to":[12,109,164,172],"inhibit":[13,41],"the":[14,51,60,75,84,152,167,178,211,236,250,261,281,288],"growth":[15],"herpes":[17],"simplex":[18],"virus":[19,45,76,139],"types":[20],"I":[21],"and":[22,25,112,206,215,238,253],"II":[23],"(HSV-I":[24],"HSV-II)":[26],"in":[27,47,73,107,134,151,162,181,235,291],"human":[28],"Chang":[29,116,192,294],"cells.":[30,49,155,183,295],"In":[31,50,156,222],"contrast,":[32,157],"much":[33],"lower":[34],"(10-100":[36],"interferon":[40],"replication":[42],"encephalomyocarditis":[44],"(EMCV)":[46],"these":[48,54,182,272],"HSV-infected":[52,154,293],"cells":[53,117,136,193],"high":[55,158],"did":[57],"not":[58],"prevent":[59],"virus-induced":[61],"shut":[62],"off":[63],"host":[65],"protein":[66,90],"synthesis.":[67],"The":[68,269],"were":[70,105,132,149,160,241,245,257],"more":[71],"effective":[72],"reducing":[74],"yield":[77],"HSV-I":[79,89,199],"than":[80,128,219],"HSV-II.":[82,100],"At":[83],"above":[85],"concentrations":[86],"they":[87],"inhibited":[88],"synthesis":[91],"but":[92],"had":[93],"little":[94],"apparent":[95],"effect":[96],"on":[97,138],"that":[98,169],"Similar":[101],"amounts":[102,226],"(2'-5')oligo(adenylate)s":[104,131],"synthesised":[106],"response":[108,163],"HSV-I,":[110],"HSV-II":[111],"EMCV":[113],"infection":[114,140,197],"after":[118,196],"treatment":[119],"with":[120,175,198,203],"interferons.":[124],"No":[125],"(i.e.":[126],"less":[127],"1":[129],"nM)":[130],"found":[133,161],"control":[135],"alone.":[141],"Only":[142],"low":[143,283],"levels":[144,159,174,284],"ppp(A2'p)nA-specific":[146],"rRNA":[147,207],"cleavage":[148,208],"observed":[150],"interferon-treated":[153,191],"EMCV,":[165],"despite":[166],"fact":[168],"ppp(A2'p)nA":[170],"accumulated":[171],"similar":[173],"each":[176],"three":[179],"viruses":[180],"High-performance":[184],"liquid":[185],"chromatographic":[186],"analysis":[187],"material":[189],"from":[190],"18":[194],"h":[195],"HSV-II,":[201],"combined":[202],"radiobinding,":[204],"radioimmune":[205,239],"assays,":[209,240],"confirmed":[210],"presence":[212,270],"ppp(A2'p)2A":[214],"ppp(A2'p)3A":[216],"at":[217],"greater":[218],"nanomolar":[220],"concentration.":[221],"addition,":[223],"apparently":[224],"equivalent":[225],"two":[228],"other":[229],"putative":[230],"(2'-5')oligo(adenylate)":[231],"derivatives":[232],"which":[233],"compete":[234],"radiobinding":[237],"present.":[242],"These":[243],"compounds":[244,275],"only":[246],"weak":[247],"activators":[248],"ppp(A2'p)nA-dependent":[251,289],"RNase":[252,265,290],"under":[254],"appropriate":[255],"conditions":[256],"capable":[258],"inhibiting":[260],"activation":[262,286],"this":[264],"by":[266],"authentic":[267],"ppp(A2'p)nA.":[268],"potentially":[273],"inhibitory":[274],"provides":[276],"a":[277],"possible":[278],"explanation":[279],"for":[280],"relatively":[282],"interferon-treated,":[292]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000110844","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
